EGFR and neoplasm: Despite heterogeneity of levels of EGFR and HER3 expression, levels of MAPK and AKT phosphorylation, and overall growth rates among the different cell lines, the inhibition of tumour cell proliferation by AG1478 alone or in combination with trastuzumab was correlated with levels of expression of HER2.